90-120 mg q4 weeks is the dosing for which product?

Prepare for the Schizophrenia and Psychotic Disorders Test. Enhance your learning with flashcards and multiple choice questions. Each question includes detailed explanations and important insights. Get ready to excel in your exam!

Multiple Choice

90-120 mg q4 weeks is the dosing for which product?

Explanation:
The key idea here is matching the dosing interval and amount to the specific long-acting antipsychotic. A monthly subcutaneous injection in a fixed monthly dose of 90 mg or 120 mg is characteristic of Risperidone RBP-7000, brand Perseris. That product is designed for monthly administration, hence 90-120 mg every 4 weeks. Other options use different schedules: Risperidone Consta is an intramuscular injection given every 2 weeks; Aripiprazole Maintena is monthly as well but at a different dose range (typically around 300–400 mg); Paliperidone palmitate 3-monthly (Invega Trinza) is every 3 months. So the 90–120 mg every 4 weeks pattern fits Perseris best.

The key idea here is matching the dosing interval and amount to the specific long-acting antipsychotic. A monthly subcutaneous injection in a fixed monthly dose of 90 mg or 120 mg is characteristic of Risperidone RBP-7000, brand Perseris. That product is designed for monthly administration, hence 90-120 mg every 4 weeks.

Other options use different schedules: Risperidone Consta is an intramuscular injection given every 2 weeks; Aripiprazole Maintena is monthly as well but at a different dose range (typically around 300–400 mg); Paliperidone palmitate 3-monthly (Invega Trinza) is every 3 months. So the 90–120 mg every 4 weeks pattern fits Perseris best.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy